CIK 0000816956
- Large accelerated filer
CONMED Corp
Sign in to watch- Ticker
- CNMD
- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 160977505
- Phone
- +1 727-214-2974
- Business address
- 11311 CONCEPT BOULEVARD, LARGO, FL, 33773
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-01 | Berge Terence M VP-Corporate Controller | Option exercise | +5,400 | $78.76 | $425K | 6,404 |
| 2021-03-01 | Berge Terence M VP-Corporate Controller | Sale | −5,400 | $122.50 | $662K | 1,004 |
| 2021-03-01 | Berge Terence M VP-Corporate Controller | Option exercise | +2,550 | $97.69 | $249K | 3,554 |
| 2021-03-01 | Berge Terence M VP-Corporate Controller | Sale | −2,550 | $122.50 | $312K | 1,004 |
| 2021-03-01 | Berge Terence M VP-Corporate Controller | Option exercise · Options To Purchase Common Stock | −3,860 | 0 | ||
| 2021-03-01 | Berge Terence M VP-Corporate Controller | Option exercise · Options To Purchase Common Stock | −2,800 | 2,800 | ||
| 2021-03-01 | Berge Terence M VP-Corporate Controller | Option exercise · Options To Purchase Common Stock | −2,700 | 5,400 | ||
| 2021-03-01 | Berge Terence M VP-Corporate Controller | Option exercise · Options To Purchase Common Stock | −5,400 | 8,100 | ||
| 2021-03-01 | Berge Terence M VP-Corporate Controller | Option exercise · Options To Purchase Common Stock | −2,550 | 10,200 | ||
| 2021-03-01 | Berge Terence M VP-Corporate Controller | Grant or award · Options To Purchase Common Stock | +12,000 | 12,000 | ||
| 2021-02-19 | TRYNISKI MARK E Director | Sale | −90 | $122.05 | $11K | 46,289 |
| 2021-02-19 | TRYNISKI MARK E Director | Sale | −3,400 | $122.23 | $416K | 42,889 |
| 2021-02-18 | Hartman Curt R President, CEO and Chair | Sale | −11,900 | $119.73 | $1.4M | 125,957 |
| 2021-02-18 | Hartman Curt R President, CEO and Chair | Sale | −3,100 | $120.68 | $374K | 122,857 |
| 2021-02-16 | TRYNISKI MARK E Director | Option exercise | +1,000 | $27.63 | $28K | 43,889 |
| 2021-02-16 | TRYNISKI MARK E Director | Shares withheld for taxes | −229 | $120.69 | $28K | 43,660 |
| 2021-02-16 | TRYNISKI MARK E Director | Option exercise | +1,000 | $26.09 | $26K | 44,660 |
| 2021-02-16 | TRYNISKI MARK E Director | Shares withheld for taxes | −217 | $120.69 | $26K | 44,443 |
| 2021-02-16 | TRYNISKI MARK E Director | Option exercise | +1,000 | $32.93 | $33K | 45,443 |
| 2021-02-16 | TRYNISKI MARK E Director | Shares withheld for taxes | −273 | $120.69 | $33K | 45,170 |
Page 38 of 68 · 1,345 trades